Eli Manning just received news that will sting a little longer. The former New York Giants quarterback was once again left out by Pro Football Hall of Fame voters, marking his second straight miss, according to The Athletic.

Is there another beat-and-raise in the pharmaceutical giant's near future?

Eli Lilly signs major deals with Repertoire Immune and Seamless Therapeutics, committing billions to autoimmune disease treatments and gene therapies targeting hearing loss.

Bill Belichick won't be the only snub for the Pro Football Hall of Fame's class of 2026. News broke Tuesday that Belichick -- despite winning eight Super Bowls, including six as coach of the New England Patriots -- did not receive enough votes to receive induction into the Hall of Fame during his first year of eligibility.

The target action date for orforglipron is now April 10.

Eli Lilly and Company (NYSE:LLY) is among the most profitable healthcare stocks to buy. On January 26, Srikripa Devarakonda, an analyst at Truist Financial, maintained a Buy rating on Eli Lilly and Company (NYSE:LLY),

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE:LLY) plans to invest over US$3.5b in a new Pennsylvania manufacturing facility focused on next ...

If you're worried you missed the boat on Eli Lilly, you shouldn't be, as there are other healthcare companies involved in the development of GLP-1 drugs, which could generate some strong growth in the future. One stock you'll want to keep an eye on is Amgen ( AMGN +0.21%).